Literature DB >> 24700321

Immunologic applications of conditional gene modification technology in the mouse.

Suveena Sharma1, Jinfang Zhu1.   

Abstract

Since the success of homologous recombination in altering mouse genome and the discovery of Cre-loxP system, the combination of these two breakthroughs has created important applications for studying the immune system in the mouse. Here, we briefly summarize the general principles of this technology and its applications in studying immune cell development and responses; such implications include conditional gene knockout and inducible and/or tissue-specific gene over-expression, as well as lineage fate mapping. We then discuss the pros and cons of a few commonly used Cre-expressing mouse lines for studying lymphocyte development and functions. We also raise several general issues, such as efficiency of gene deletion, leaky activity of Cre, and Cre toxicity, all of which may have profound impacts on data interpretation. Finally, we selectively list some useful links to the Web sites as valuable mouse resources.
Copyright © 2014 John Wiley & Sons, Inc.

Entities:  

Keywords:  Cre; bacterial artificial chromosome (BAC); conditional knockout; fate mapping; hematopoietic cells; inducible gene expression; loxP; lymphocyte cell development and differentiation; transgenic

Mesh:

Substances:

Year:  2014        PMID: 24700321      PMCID: PMC4100247          DOI: 10.1002/0471142735.im1034s105

Source DB:  PubMed          Journal:  Curr Protoc Immunol        ISSN: 1934-3671


  78 in total

Review 1.  Cre recombinase: the universal reagent for genome tailoring.

Authors:  A Nagy
Journal:  Genesis       Date:  2000-02       Impact factor: 2.487

2.  Tight control of gene expression in mammalian cells by tetracycline-responsive promoters.

Authors:  M Gossen; H Bujard
Journal:  Proc Natl Acad Sci U S A       Date:  1992-06-15       Impact factor: 11.205

Review 3.  Development of 2A peptide-based strategies in the design of multicistronic vectors.

Authors:  Andrea L Szymczak; Dario A A Vignali
Journal:  Expert Opin Biol Ther       Date:  2005-05       Impact factor: 4.388

4.  Generalized lacZ expression with the ROSA26 Cre reporter strain.

Authors:  P Soriano
Journal:  Nat Genet       Date:  1999-01       Impact factor: 38.330

5.  B lymphocyte-specific, Cre-mediated mutagenesis in mice.

Authors:  R C Rickert; J Roes; K Rajewsky
Journal:  Nucleic Acids Res       Date:  1997-03-15       Impact factor: 16.971

6.  Z/EG, a double reporter mouse line that expresses enhanced green fluorescent protein upon Cre-mediated excision.

Authors:  A Novak; C Guo; W Yang; A Nagy; C G Lobe
Journal:  Genesis       Date:  2000 Nov-Dec       Impact factor: 2.487

7.  In vivo genetic ablation by Cre-mediated expression of diphtheria toxin fragment A.

Authors:  Anna Ivanova; Massimo Signore; Nadia Caro; Nicholas D E Greene; Andrew J Copp; Juan Pedro Martinez-Barbera
Journal:  Genesis       Date:  2005-11       Impact factor: 2.487

8.  Codon-improved Cre recombinase (iCre) expression in the mouse.

Authors:  D R Shimshek; J Kim; M R Hübner; D J Spergel; F Buchholz; E Casanova; A F Stewart; P H Seeburg; R Sprengel
Journal:  Genesis       Date:  2002-01       Impact factor: 2.487

9.  Ligand-activated site-specific recombination in mice.

Authors:  R Feil; J Brocard; B Mascrez; M LeMeur; D Metzger; P Chambon
Journal:  Proc Natl Acad Sci U S A       Date:  1996-10-01       Impact factor: 11.205

10.  Cleavage of foot-and-mouth disease virus polyprotein is mediated by residues located within a 19 amino acid sequence.

Authors:  M D Ryan; A M King; G P Thomas
Journal:  J Gen Virol       Date:  1991-11       Impact factor: 3.891

View more
  13 in total

1.  Efficiency and Specificity of Gene Deletion in Lung Epithelial Doxycycline-Inducible Cre Mice.

Authors:  Meenal Sinha; Clifford A Lowell
Journal:  Am J Respir Cell Mol Biol       Date:  2017-08       Impact factor: 6.914

Review 2.  Functions of Murine Dendritic Cells.

Authors:  Vivek Durai; Kenneth M Murphy
Journal:  Immunity       Date:  2016-10-18       Impact factor: 31.745

3.  Modulation of Endoplasmic Reticulum Stress Controls CD4+ T-cell Activation and Antitumor Function.

Authors:  Jessica E Thaxton; Caroline Wallace; Brian Riesenberg; Yongliang Zhang; Chrystal M Paulos; Craig C Beeson; Bei Liu; Zihai Li
Journal:  Cancer Immunol Res       Date:  2017-06-22       Impact factor: 11.151

4.  T-cell Dysfunction upon Expression of MYC with Altered Phosphorylation at Threonine 58 and Serine 62.

Authors:  Colin J Daniel; Carl Pelz; Xiaoyan Wang; Michael W Munks; Aaron Ko; Dhaarini Murugan; Sarah A Byers; Eleonora Juarez; Karyn L Taylor; Guang Fan; Lisa M Coussens; Jason M Link; Rosalie C Sears
Journal:  Mol Cancer Res       Date:  2022-07-06       Impact factor: 6.333

5.  Protein tyrosine phosphatase nonreceptor type 2 controls colorectal cancer development.

Authors:  Egle Katkeviciute; Larissa Hering; Ana Montalban-Arques; Philipp Busenhart; Marlene Schwarzfischer; Roberto Manzini; Javier Conde; Kirstin Atrott; Silvia Lang; Gerhard Rogler; Elisabeth Naschberger; Vera S Schellerer; Michael Stürzl; Andreas Rickenbacher; Matthias Turina; Achim Weber; Sebastian Leibl; Gabriel E Leventhal; Mitchell Levesque; Onur Boyman; Michael Scharl; Marianne R Spalinger
Journal:  J Clin Invest       Date:  2021-01-04       Impact factor: 14.808

6.  Ldb1 is required for Lmo2 oncogene-induced thymocyte self-renewal and T-cell acute lymphoblastic leukemia.

Authors:  LiQi Li; Apratim Mitra; Kairong Cui; Bin Zhao; Seeyoung Choi; Jan Y Lee; Daniel B Stamos; Dalal El-Khoury; Claude Warzecha; Karl Pfeifer; Joyce Hardwick; Keji Zhao; Bryan Venters; Utpal P Davé; Paul E Love
Journal:  Blood       Date:  2020-06-18       Impact factor: 22.113

7.  Stabilization of Foxp3 by Targeting JAK2 Enhances Efficacy of CD8 Induced Regulatory T Cells in the Prevention of Graft-versus-Host Disease.

Authors:  Supinya Iamsawat; Anusara Daenthanasanmak; Jessica Heinrichs Voss; Hung Nguyen; David Bastian; Chen Liu; Xue-Zhong Yu
Journal:  J Immunol       Date:  2018-09-21       Impact factor: 5.422

8.  The Transcription Factor NFATc1 Supports the Rejection of Heterotopic Heart Allografts.

Authors:  Johannes Baur; Christoph Otto; Ulrich Steger; Stefan Klein-Hessling; Khalid Muhammad; Tobias Pusch; Krisna Murti; Rhoda Wismer; Christoph-Thomas Germer; Ingo Klein; Nora Müller; Edgar Serfling; Andris Avots
Journal:  Front Immunol       Date:  2018-06-12       Impact factor: 7.561

9.  T Cell-Intrinsic CDK6 Is Dispensable for Anti-Viral and Anti-Tumor Responses In Vivo.

Authors:  Klara Klein; Agnieszka Witalisz-Siepracka; Dagmar Gotthardt; Benedikt Agerer; Felix Locker; Reinhard Grausenburger; Vanessa Maria Knab; Andreas Bergthaler; Veronika Sexl
Journal:  Front Immunol       Date:  2021-06-24       Impact factor: 7.561

10.  Seventeen-Year Journey Working With a Master.

Authors:  Jinfang Zhu
Journal:  Front Immunol       Date:  2018-05-02       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.